LT - USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL) CYCLOPENT-1-ENE-1-CARBOXYLIC ACID AND RELATED COMPOUNDS, (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID IN THE TREATMENT OF FRAGILE X SYNDROME OR FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME
EN - USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL) CYCLOPENT-1-ENE-1-CARBOXYLIC ACID AND RELATED COMPOUNDS, (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID IN THE TREATMENT OF FRAGILE X SYNDROME OR FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/196 |
(2006.01) |
|
|
A61K 31/00 |
(2006.01) |
|
|
A61K 31/185 |
(2006.01) |
|
|
A61K 31/19 |
(2006.01) |
|
|
A61P 25/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
3813816 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
19815892.5 |
|
Date of filing the European patent application |
2019-06-07 |
| (97) |
Date of publication of the European application |
2021-05-05 |
| (45) |
Date of publication and mention of the grant of the patent |
2023-06-07
|
| (46) |
Date of publication of the claims translation |
|
PCT application
| (86) |
Number |
PCT/US2019/035934 |
|
Date |
2019-06-07 |
PCT application publication
| (87) |
Number |
WO 2019/236938 |
|
Date |
2019-12-12 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
201862681913 P |
2018-06-07
|
US |
Inventors
| (72) |
DURING, Matthew , US
ABRAHAMS, Brett , US
|
Grantee
| (73) |
Ovid Therapeutics Inc. ,
441 9th Avenue,, New York, NY 10001,
US
|
Title
| (54) |
USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL) CYCLOPENT-1-ENE-1-CARBOXYLIC ACID AND RELATED COMPOUNDS, (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID IN THE TREATMENT OF FRAGILE X SYNDROME OR FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME |
| |
USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL) CYCLOPENT-1-ENE-1-CARBOXYLIC ACID AND RELATED COMPOUNDS, (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID IN THE TREATMENT OF FRAGILE X SYNDROME OR FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME |
